Screener
Eligibility screening
A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
4 US sites in MA, MN, NY, WA
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.